Recommendations for robust and reproducible preclinical research in personalised medicine

V Fosse, E Oldoni, F Bietrix, A Budillon… - BMC medicine, 2023 - Springer
Background Personalised medicine is a medical model that aims to provide tailor-made
prevention and treatment strategies for defined groups of individuals. The concept brings …

Study designs for clinical trials applied to personalised medicine: a scoping review

C Superchi, FB Bouvier, C Gerardi, M Carmona… - BMJ open, 2022 - bmjopen.bmj.com
Objective Personalised medicine (PM) allows treating patients based on their individual
demographic, genomic or biological characteristics for tailoring the 'right treatment for the …

Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine

G Dunn, R Emsley, H Liu, S Landau - Clinical trials, 2013 - journals.sagepub.com
Background The development of personalised (stratified) medicine is intrinsically dependent
on an understanding of treatment-effect mechanisms (effects on therapeutic targets that …

Evaluating translational methods for personalized medicine—a scoping review

V Fosse, E Oldoni, C Gerardi, R Banzi… - Journal of Personalized …, 2022 - mdpi.com
The introduction of personalized medicine, through the increasing multi-omics
characterization of disease, brings new challenges to disease modeling. The scope of this …

[图书][B] Treating individuals: from randomised trials to personalised medicine

PM Rothwell - 2007 - books.google.com
Inspired by a hugely successful series entitled Treating Individuals, originally published in
The Lancet, this volume will become essential reading for any professional involved with …

Horizon 2020: European perspectives in healthcare sciences and implementation

I Norstedt - EPMA Journal, 2014 - Springer
The potential benefits that preventive, predictive and personalised medicine approaches
can bring to healthcare are discussed with much interest throughout the EU. This novel …

Can real-world data really replace randomised clinical trials?

SV Ramagopalan, A Simpson, C Sammon - BMC medicine, 2020 - Springer
Background Classically, randomised controlled trials (RCTs) are considered the gold
standard for demonstrating product efficacy for the regulatory approval of medicines …

Personalised health care, the need for reassessment. A HTA perspective far beyond cost-effectiveness

I Gutiérrez-Ibarluzea - Italian Journal of Public Health, 2012 - ijphjournal.it
Background: personalised health care has been claimed to play an outstanding role in the
future health services. In fact, health care systems will have to face changes in their work …

How personalized are benefit and harm results of randomized trials? A systematic review

A Yu, Y Jeyakumar, M Wang, J Lee, M Marcucci… - Journal of Clinical …, 2020 - Elsevier
Objectives This study aimed to review the degree of personalization of benefit and harm in
the reporting of recent high-profile randomized controlled trials (RCTs) involving …

Design of clinical trials in integrative medicine: The issue of personalization

KW Chan, J Liu, Z Bian - European Journal of Integrative Medicine, 2024 - Elsevier
Introduction Classic randomized controlled trial design provides information about the
effectiveness of a treatment at population level. In clinical practice based on precision …